Literature DB >> 30819040

Perfusion strategy and mid-term results of 58 consecutive pulmonary endarterectomy.

Shujie Yan1, Song Lou1, Jiade Zhu2, Sheng Liu2, Yu Zhao3, Yunhu Song2, Hui Wang1, Bingyang Ji1.   

Abstract

OBJECTIVE: The aim of this retrospective study was to review and report short-term and mid-term outcomes of pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension at our institute in the recent 2 years and to describe perfusion strategy.
METHODS: A total of 58 consecutive patients with chronic thromboembolic pulmonary hypertension underwent pulmonary endarterectomy under deep hypothermia circulatory arrest with an established perfusion practice between November 2015 and December 2017. Peri-operative data and patients' outcome were retrospectively analyzed.
RESULTS: Mean pulmonary artery pressure was decreased (49 (40-56) mmHg vs 27 (20-31) mmHg, p < 0.001), and pulmonary vascular resistance (724 (538-1108) vs 206 (141-284) dyn second cm-5, p < 0.001) improved significantly after surgery. In-hospital mortality was 1.7% and postoperative complication rate was 27.6%. Antipsychotic medication of olanzapine was prescribed for 36 patients (62.1%), which was independently related to total deep hypothermic circulatory arrest time, postoperative blood potassium concentration, and hematocrit. The majority of patients recovered uneventfully with good mid-term cardiac function (New York Heart Association I-II: 98.1%) and neurological outcome (Glasgow Outcome Scale-Extended Upper Good Recovery: 74.1% and Lower Good Recovery: 20.3%). Mid-term neurological outcome was associated with post-pulmonary endarterectomy antipsychotic medication.
CONCLUSION: Short-term and mid-term outcome after pulmonary endarterectomy was comparable to high-volume centers. Incidence of post-pulmonary endarterectomy delirium was relatively high and associated with mid-term neurological outcome. Total deep hypothermic circulatory arrest time, postoperative blood potassium concentration, and hematocrit were independent risk factors of postoperative olanzapine medication. More efforts and further research are required to optimize the neuroprotection of perfusion practice.

Entities:  

Keywords:  cerebral protection; deep hypothermia circulatory arrest; delirium; perfusion strategy; pulmonary endarterectomy

Year:  2019        PMID: 30819040     DOI: 10.1177/0267659119831518

Source DB:  PubMed          Journal:  Perfusion        ISSN: 0267-6591            Impact factor:   1.972


  2 in total

1.  The long-term survival in patients with chronic thromboembolic pulmonary hypertension: experience from a single center in China.

Authors:  Song Hu; Jiang-Shan Tan; Sheng Liu; Ting-Ting Guo; Wu Song; Fu-Hua Peng; Yan Wu; Xin Gao; Lu Hua
Journal:  J Thromb Thrombolysis       Date:  2021-10-27       Impact factor: 2.300

2.  Pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension: a systematic review.

Authors:  John D L Brookes; Crystal Li; Sally T W Chung; Elizabeth M Brookes; Michael L Williams; Nicholas McNamara; Sofia Martin-Suarez; Antonio Loforte
Journal:  Ann Cardiothorac Surg       Date:  2022-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.